110 related articles for article (PubMed ID: 37546763)
1. Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking.
Wilkinson CS; Blount HL; Davis S; Rojas G; Wu L; Murphy NP; Schwendt M; Knackstedt LA
bioRxiv; 2023 Jul; ():. PubMed ID: 37546763
[TBL] [Abstract][Full Text] [Related]
2. Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking.
Wilkinson CS; Blount HL; Davis S; Rojas G; Wu L; Murphy NP; Schwendt M; Knackstedt LA
Sci Rep; 2023 Nov; 13(1):19174. PubMed ID: 37932476
[TBL] [Abstract][Full Text] [Related]
3. The galanin receptor-3 antagonist, SNAP 37889, inhibits cue-induced reinstatement of alcohol-seeking and increases c-Fos expression in the nucleus accumbens shell of alcohol-preferring rats.
Wilson KE; Limburg S; Duggan MK; Lawther AJ; Williams SJ; Lawrence AJ; Hale MW; Djouma E
J Psychopharmacol; 2018 Aug; 32(8):911-921. PubMed ID: 29926762
[TBL] [Abstract][Full Text] [Related]
4. The effect of concurrent access to alcohol and oxycodone on self-administration and reinstatement in rats.
Amico KN; Arnold ME; Dourron MS; Solomon MG; Schank JR
Psychopharmacology (Berl); 2022 Oct; 239(10):3277-3286. PubMed ID: 35972517
[TBL] [Abstract][Full Text] [Related]
5. mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate cue-induced reinstatement of ethanol-seeking behavior.
Sinclair CM; Cleva RM; Hood LE; Olive MF; Gass JT
Pharmacol Biochem Behav; 2012 May; 101(3):329-35. PubMed ID: 22296815
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior.
Illenberger JM; Flores-Ramirez FJ; Pascasio G; Franco M; Mendonsa B; Martin-Fardon R
J Psychopharmacol; 2024 Jun; ():2698811241260989. PubMed ID: 38888086
[TBL] [Abstract][Full Text] [Related]
7. Cue-induced reinstatement of alcohol-seeking behavior is associated with increased CaMKII T286 phosphorylation in the reward pathway of mice.
Salling MC; Hodge CJ; Psilos KE; Eastman VR; Faccidomo SP; Hodge CW
Pharmacol Biochem Behav; 2017 Dec; 163():20-29. PubMed ID: 29100991
[TBL] [Abstract][Full Text] [Related]
8. Deep brain stimulation of the nucleus accumbens shell attenuates cue-induced reinstatement of both cocaine and sucrose seeking in rats.
Guercio LA; Schmidt HD; Pierce RC
Behav Brain Res; 2015 Mar; 281():125-30. PubMed ID: 25529183
[TBL] [Abstract][Full Text] [Related]
9. Ranking the contribution of behavioral measures comprising oxycodone self-administration to reinstatement of drug-seeking in male and female rats.
Guha SK; Alonso-Caraballo Y; Driscoll GS; Babb JA; Neal M; Constantino NJ; Lintz T; Kinard E; Chartoff EH
Front Behav Neurosci; 2022; 16():1035350. PubMed ID: 36505730
[TBL] [Abstract][Full Text] [Related]
10. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.
Jupp B; Krstew E; Dezsi G; Lawrence AJ
Br J Pharmacol; 2011 Feb; 162(4):880-9. PubMed ID: 20973776
[TBL] [Abstract][Full Text] [Related]
11. Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats.
Hinds NM; Wojtas ID; Gallagher CA; Corbett CM; Manvich DF
Front Behav Neurosci; 2023; 17():1143373. PubMed ID: 37465001
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats.
Fulenwider HD; Nennig SE; Hafeez H; Price ME; Baruffaldi F; Pravetoni M; Cheng K; Rice KC; Manvich DF; Schank JR
Addict Biol; 2020 Nov; 25(6):e12822. PubMed ID: 31830773
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Alcohol Extinction and Cue-Induced Reinstatement by Specific Projections among Medial Prefrontal Cortex, Nucleus Accumbens, and Basolateral Amygdala.
Keistler CR; Hammarlund E; Barker JM; Bond CW; DiLeone RJ; Pittenger C; Taylor JR
J Neurosci; 2017 Apr; 37(17):4462-4471. PubMed ID: 28336571
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking.
Weiland A; Garcia S; Knackstedt LA
Front Pharmacol; 2015; 6():44. PubMed ID: 25805996
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats.
Hinds NM; Wojtas ID; Gallagher CA; Corbett CM; Manvich DF
bioRxiv; 2023 Jun; ():. PubMed ID: 37333293
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
18. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.
Bossert JM; Hoots JK; Fredriksson I; Adhikary S; Zhang M; Venniro M; Shaham Y
Eur J Neurosci; 2019 Aug; 50(3):2075-2085. PubMed ID: 29779230
[TBL] [Abstract][Full Text] [Related]
19. ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking.
Illenberger JM; Flores-Ramirez FJ; Matzeu A; Lütjens R; Martin-Fardon R
Neuropharmacology; 2023 Nov; 238():109666. PubMed ID: 37463637
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptor activation in the medial shell of nucleus accumbens promotes alcohol consumption, self-administration and cue-induced reinstatement.
Richard JM; Fields HL
Neuropharmacology; 2016 Sep; 108():14-23. PubMed ID: 27089981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
